An update on SPECTA
4 Mar 2016
The next generation sequencing service provider for SPECTA, 14M Genomics, has decided to close down operations due to withdrawal of funding from Syncona LLP, the sole investor of 14M Genomics. At this time, more than 850 patients have been included in SPECTAcolor and more than 120 patients have been included in SPECTAlung. More than 500 tumor samples have been tested by next generation sequencing and result reports are available.
EORTC is in the process of identifying a new service provider for next generation sequencing services. In addition, we have started talking to providers of different technologies, realizing that next generation sequencing is a powerful tool but often cannot be used in isolation for patient selection for clinical trials. Depending on the scientific and financing requirements of EORTC groups for the SPECTA platforms, different technologies can be used routinely or selectively for various patient cohorts. The EORTC board remains committed to the SPECTA philosophy and platforms and, together with the EORTC HQ and the SPECTA steering committees, are working hard to identify an adequate quality provider for molecular testing. The collection of biological material and clinical data continues in the same manner, as well as testing within specific clinical projects. More information will follow as soon as it becomes available.
Related News
SISAQOL-IMI Consortium Launches Final Recommendations
6 Feb 2025
World Cancer Day 2025: EORTC’s commitment to older patients
4 Feb 2025
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024
Pink October at EORTC: Over 60 years of impactful breast cancer research
29 Oct 2024
Spotlight on ENA 2024 News
25 Oct 2024
Do regulations and policies undermine the social value of independent academic research?
25 Oct 2024
EORTC Quality of Life Group’s participation to ISOQOL 2024
10 Oct 2024